Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer
- 1 July 2015
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 68 (1) , 32-39
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prostate cancer, version 1.2014.Journal of the National Comprehensive Cancer Network, 2013
- A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinomaCancer Treatment Reviews, 2009
- Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate CancerJAMA, 2008
- Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular MortalityJNCI: Journal of the National Cancer Institute, 2007
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyThe Lancet Oncology, 2006
- Androgens, insulin resistance and vascular disease in menClinical Endocrinology, 2005
- National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate CancerJNCI: Journal of the National Cancer Institute, 2003
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialThe Lancet, 2002
- Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateCA: A Cancer Journal for Clinicians, 1972